World's most advanced dengue vaccine candidate shows promise in phase 3 trial
The first dengue vaccine candidate (CYD-TDV) to reach phase 3 clinical testing has shown moderate protection (56%) against the disease in Asian children, according to new research published in The Lancet.
Jul 11, 2014
0
0